> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Biosimilar Fee Program Info Collection
- URL: https://www.fdaweb.com/comments-sought-on-biosimilar-fee-program-info-collection/
- Published: 2018-06-28T12:00:00.000Z
- Updated: 2026-09-15T00:16:45.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141794

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Biosimilars User Fee Program” (OMB Control Number 0910-0718). To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-14057.pdf?ref=fdaweb.com).